DPHARMA
Quarterly rpt on consolidated results for the financial period ended 30 Sep 2024
| DUOPHARMA BIOTECH BERHAD |
| Financial Year End | 31 Dec 2024 |
| Quarter | 3 Qtr |
| Quarterly report for the financial period ended | 30 Sep 2024 |
| The figures | have not been audited |
- Default Currency
- Other Currency
Currency: Malaysian Ringgit (MYR)
SUMMARY OF KEY FINANCIAL INFORMATION
|
INDIVIDUAL PERIOD
|
CUMULATIVE PERIOD
|
||||
CURRENT YEAR QUARTER
|
PRECEDING YEAR CORRESPONDING QUARTER |
CURRENT YEAR TO DATE
|
PRECEDING YEAR CORRESPONDING PERIOD |
||
|
30 Sep 2024
|
30 Sep 2023
|
30 Sep 2024
|
30 Sep 2023
|
||
|
MYR'000
|
MYR'000
|
MYR'000
|
MYR'000
|
||
| 1 | Revenue |
208,732
|
169,235
|
620,024
|
537,226
|
| 2 | Profit/(loss) before tax |
20,520
|
11,427
|
62,581
|
56,233
|
| 3 | Profit/(loss) for the period |
15,595
|
8,970
|
47,562
|
44,143
|
| 4 | Profit/(loss) attributable to ordinary equity holders of the parent |
15,595
|
8,970
|
47,562
|
44,143
|
| 5 | Basic earnings/(loss) per share (Subunit) |
1.62
|
0.93
|
4.94
|
4.61
|
| 6 | Proposed/Declared dividend per share (Subunit) |
0.00
|
0.00
|
1.00
|
0.50
|
AS AT END OF CURRENT QUARTER
|
AS AT PRECEDING FINANCIAL YEAR END
|
||||
| 7 |
Net assets per share attributable to ordinary equity holders of the parent |
0.7200
|
0.7100
|
||
Definition of Subunit:
In a currency system, there is usually a main unit (base) and
subunit that is a fraction amount of the main unit.
Example for the subunit as follows:
| Country | Base Unit | Subunit |
| Malaysia | Ringgit | Sen |
| United States | Dollar | Cent |
| United Kingdom | Pound | Pence |
Announcement Info
| Company Name | DUOPHARMA BIOTECH BERHAD |
| Stock Name | DPHARMA |
| Date Announced | 08 Nov 2024 |
| Category | Financial Results |
| Reference Number | FRA-07112024-00004 |